Identifying and preventing the return of Helicobacter pylori infections in patients.

Project 3: Molecular Risk Stratification of Gastric Precancerous Lesions

NIH-funded research Stanford University · NIH-10932178

This study is looking for ways to prevent Helicobacter pylori infections from coming back and to help people who are at risk of developing stomach problems by using new technology to find hidden bacteria and understand their health better.

Quick facts

Grant typeP01 program project
Study typeNIH-funded research
Funding institutionStanford University NIH-funded
Lab location1 site (Stanford, United States)
Project IDNIH-10932178 on NIH RePORTER

What this research studies

This research focuses on reducing the recurrence of Helicobacter pylori (Hp) infections, which can lead to serious gastric conditions. By using advanced gene sequencing technology, the study aims to detect hidden Hp colonies that survive standard treatments. Patients who are Hp negative will be monitored through RNA sequencing to identify risk factors for gastric intestinal metaplasia. The goal is to develop a reliable test that can predict and prevent the progression of gastric diseases in these patients.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals who have been treated for Helicobacter pylori but are currently Hp negative.

Not a fit: Patients who have active Helicobacter pylori infections or those who have not undergone treatment may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could significantly lower the rates of Hp recurrence and improve outcomes for patients at risk of gastric cancer.

How similar studies have performed: Previous research has shown promise in using molecular techniques for detecting persistent infections, indicating potential success for this approach.

Where this research is happening

Stanford, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-10 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.